JPH0143727B2 - - Google Patents

Info

Publication number
JPH0143727B2
JPH0143727B2 JP56146946A JP14694681A JPH0143727B2 JP H0143727 B2 JPH0143727 B2 JP H0143727B2 JP 56146946 A JP56146946 A JP 56146946A JP 14694681 A JP14694681 A JP 14694681A JP H0143727 B2 JPH0143727 B2 JP H0143727B2
Authority
JP
Japan
Prior art keywords
seizures
day
waves
slow
became
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56146946A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5849313A (ja
Inventor
Kazutoyo Inanaga
Takeji Nakawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP56146946A priority Critical patent/JPS5849313A/ja
Priority to IT68101/82A priority patent/IT1157060B/it
Priority to US06/416,706 priority patent/US4421745A/en
Priority to DE19823234061 priority patent/DE3234061A1/de
Priority to FR8215612A priority patent/FR2512673B1/fr
Publication of JPS5849313A publication Critical patent/JPS5849313A/ja
Publication of JPH0143727B2 publication Critical patent/JPH0143727B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP56146946A 1981-09-16 1981-09-16 抗てんかん剤 Granted JPS5849313A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP56146946A JPS5849313A (ja) 1981-09-16 1981-09-16 抗てんかん剤
IT68101/82A IT1157060B (it) 1981-09-16 1982-02-16 Prodotto antiepilettico
US06/416,706 US4421745A (en) 1981-09-16 1982-09-10 Antiepileptics
DE19823234061 DE3234061A1 (de) 1981-09-16 1982-09-14 Antiepileptika
FR8215612A FR2512673B1 (fr) 1981-09-16 1982-09-15 Sels physiologiquement acceptables de l'acide g-butyrolactone-g-carbonyl-histidyl-prolinamide, ayant des proprietes anti-epileptiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56146946A JPS5849313A (ja) 1981-09-16 1981-09-16 抗てんかん剤

Publications (2)

Publication Number Publication Date
JPS5849313A JPS5849313A (ja) 1983-03-23
JPH0143727B2 true JPH0143727B2 (enExample) 1989-09-22

Family

ID=15419146

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56146946A Granted JPS5849313A (ja) 1981-09-16 1981-09-16 抗てんかん剤

Country Status (5)

Country Link
US (1) US4421745A (enExample)
JP (1) JPS5849313A (enExample)
DE (1) DE3234061A1 (enExample)
FR (1) FR2512673B1 (enExample)
IT (1) IT1157060B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63316724A (ja) * 1987-06-19 1988-12-26 Nippon Shinyaku Co Ltd 抗けいれん剤
US5462740A (en) * 1993-09-17 1995-10-31 Athena Neurosciences, Inc. Rectally-administered, epileptic-seizure-inhibiting composition
DE10025948A1 (de) * 2000-05-26 2001-11-29 Gruenenthal Gmbh Wirkstoffkombination
CA2605122A1 (en) * 2005-03-09 2006-09-14 Roger Williams Hospital Thyrotropin-releasing hormone analogs and method of use
US20090143450A1 (en) * 2005-05-06 2009-06-04 University Of Maryland, Baltimore Method for treating central pain syndrom or for inducing centrally generated pain in an animal model

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944308B2 (ja) * 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド

Also Published As

Publication number Publication date
US4421745A (en) 1983-12-20
IT1157060B (it) 1987-02-11
JPS5849313A (ja) 1983-03-23
IT8268101A1 (it) 1983-08-16
IT8268101A0 (it) 1982-09-15
DE3234061C2 (enExample) 1990-12-20
FR2512673A1 (fr) 1983-03-18
FR2512673B1 (fr) 1986-04-11
DE3234061A1 (de) 1983-03-24

Similar Documents

Publication Publication Date Title
Ferber et al. Massage therapy by mothers and trained professionals enhances weight gain in preterm infants
KR20020097182A (ko) 수면을 개선시키는 방법 및 조성물
Druckman et al. Laughter in epilepsy
US20180221319A1 (en) Methods of treating seizure disorders and prader-willi syndrome
US12285397B2 (en) Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
US20100168053A1 (en) Oral delivery system for methylcobalamin to treat disorders
JPH0143727B2 (enExample)
Lambrini et al. Sleep and health: Role of dopamine
US4536403A (en) Method for treating neuroleptic induced tardive dyskinesia
JP2014065695A (ja) ロイシンを含有する睡眠改善剤
ES2203210T3 (es) Uso de un agonista de receptor nicotinico para la fabricacion de un medicamento para el tratamiento del trastorno obsesivo compulsivo.
JPH0283317A (ja) 精神分裂病治療剤
Haenggeli et al. Brief report: two sisters with Rett syndrome
Pazulinec et al. Psychological treatment approaches to psychogenic vomiting and rumination
EP4376954A1 (en) Lemborexant for use in methods of treating irregular sleep-wake rhythm disorder and circadian rhythm sleep disorders associated with neurodegenerative diseases
JP2019006717A (ja) 経口睡眠改善剤
TW202539621A (zh) 用於治療巴金森氏症的治療劑
Jobe et al. Three children with a syndrome of obesity and overgrowth, atypical psychosis, and seizures: a problem in neuropsychopharmacology
Brown et al. Rett syndrome
Large The Marcus-Gunn Phenomenon: Fortuitous Desensitisation Using Biofeedback
Hashimoto et al. Door syndrome: Deafness, onychoosteodystrophy and mental retardation
Clawson For Patients Who Are Ambulatory during Treatment:" Ambulatory Insulin"
Fowler Funny turns—neurological
JPH05132423A (ja) 覚醒の増加および維持をもたらす医薬組成物